Applications of artificial intelligence in drug discovery for neurological diseases.
AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. π€π
June 19, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
Artificial intelligence applications in rare and intractable diseases: Advances, challenges, and future directions.
AI transforms rare disease diagnosis and treatment, addressing 3.5%-5.9% of global cases. Key advancements and challenges discussed. π€π
June 10, 2025
Newcastle Hospitals Develops Data Platform for Enhanced Medical Research
Newcastle Hospitals is enhancing medical research with a new data platform. This aims to improve patient outcomes and support innovation. ππ₯
June 6, 2025
Invitation for Submissions: AI in Biomedical Engineering
AI in Biomedical Engineering: Call for Papers ππ€
Submissions welcome for research on AI’s role in medical advancements. Explore innovative applications and insights.
June 4, 2025
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation.
ChatGPT enhances drug harm reviews: 49% keyword recreation, 0.17 Jaccard similarity. Effective error detection tool! ππ
May 30, 2025
National Taiwan University Hospital Launches AI for Pancreatic Cancer Imaging
National Taiwan University Hospital introduces AI for pancreatic cancer imaging, enhancing early detection and diagnostic accuracy. π₯π»
May 28, 2025
Generative AI’s Role in Advancing Drug Development
Generative AI is enhancing drug development efficiency. The DiffSMol model shows a 61.4% success rate in creating promising drug candidates. πβ¨
May 27, 2025
Persist AI Raises $12 Million in Series A Funding and Launches Cloud Lab
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. π€π
May 22, 2025
Artificial intelligence approaches for anti-addiction drug discovery.
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. ππ
May 22, 2025
Amphetamine use and Parkinson’s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. π§ π
May 21, 2025